Back to mobile site

TD Cowen on Gilead Sciences (GILD): 'We Are Excited By Gilead's Recent String Of Deals'

April 8, 2026 9:02 AM EDT Send to a Friend
TD Cowen analyst Tyler Van Buren reiterated a Buy rating and $160.00 price target on Gilead Sciences (NASDAQ: GILD).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login